Compare Medpace Holdings Inc (MEDP) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Simon Property Group Inc — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Simon Property Group Inc trades at $199.42 (market cap $64.59B). The key difference: Simon Property Group Inc is far larger — about 3.8× Medpace Holdings Inc's market cap, and Simon Property Group Inc pays a 4.46% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Simon Property Group Inc for 99 Days on average.
| MEDP | SPG | |
|---|---|---|
Market Cap | $16.82B | $64.59B |
Volume | 223,093 | 1,093,907 |
Sector | Health | Real Estate |
52-Week High | $630.19 | $236.70 |
52-Week Low | $393.42 | $173.35 |
Typical Hold Time | 14 Days | 99 Days |
Enterprise Value | $16.44B | $93.03B |
Dividend Yield | — | 4.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
Simon Property Group (SPG) trades at $199.61, up 1.02% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong 2025 results, including revenue of $6.36B and net income of $4.63B, with a net margin of 72.7%. Recent news highlights leasing demand strength and a new media network launch, while analysts maintain a consensus price target of $222.90.
SPG offers value with a P/E of 14.09 and robust profitability, but faces risks from high debt levels and interest rate sensitivity. The stock's upside potential hinges on sustained retail demand and effective debt management, with institutional sentiment leaning neutral amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
